Carl v. Johnson & Johnson
(N.J., filed October 5, 2020): Urging the New Jersey Supreme Court to review a lower court’s incorrect application of the state’s expert evidence standard. Arguing that the Court needs to overturn the decision to reinforce the message of its opinion in In re Accutane. The opinion, if not reversed, will leave trial courts with great uncertainty as to the gatekeeping role in New Jersey’s many drug, tort and product lawsuits.
Bill on seat belt admissibility heads to Governor
SCOTUS Determining Whether to Hear Appeal by Defendant
Writing for The Hill, ATRA President Tiger Joyce discusses the Biden administration’s plans to allow a settlement slush fund and issues the practice has caused at the state level.
ATRA President Tiger Joyce writes about issues with a landmark talc case in Missouri and how the U.S. Supreme Court can step in.
Trial lawyers’ spending on covid ads last year surpassed $260,000